OceanPal Inc. (OP)

Blueprint Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	25.7	18.96	19.09	4.37	9.41
Revenue Growth (YoY)	35.58%	-0.67%	337.07%	-53.60%	-23.93%
Cost of Revenue	16.29	13.42	10.56	2.16	9.48
Gross Profit	9.41	5.54	8.53	2.2	-0.07
Selling, General & Admin	14.31	6.52	3.96	0.9	2.02
Other Operating Expenses	-0.08	0.13	-0.01	0	-0.24
Operating Expenses	21.42	14.32	8.85	1.85	3.93
Operating Income	-12.01	-8.78	-0.33	0.35	-4
Interest Expense	-0.11	-	-	-	-
Interest & Investment Income	0.31	0.5	-	-	-
Earnings From Equity Investments	-0.05	0	-	-	-
Other Non Operating Income (Expenses)	0.03	5.24	-	-	-
EBT Excluding Unusual Items	-11.83	-3.04	-0.33	0.35	-4
Gain (Loss) on Sale of Assets	-0.01	-	-	-	-
Asset Writedown	-6.12	-	-	-	0.2
Pretax Income	-17.86	-1.98	-0.33	0.35	-3.8
Net Income	-17.86	-1.98	-0.33	0.35	-3.8
Preferred Dividends & Other Adjustments	1.87	4.73	2.35	0.07	-
Net Income to Common	-19.73	-6.71	-2.67	0.28	-3.8
Shares Outstanding (Basic)	7	3	0	0	-
Shares Outstanding (Diluted)	7	3	0	0	-
Shares Change (YoY)	121.37%	2066.46%	153.60%	-	-
EPS (Basic)	-2.64	-2.02	-17.18	6.39	-
EPS (Diluted)	-2.64	-3.83	-17.18	4.59	-
Free Cash Flow	-22.44	-3.55	-3.58	2.33	-4.2
Free Cash Flow Per Share	-3.00	-1.05	-23.01	37.94	-
Dividend Per Share	-	-	4.000	13.333	-
Dividend Growth	-	-	-70.00%	-	-
Gross Margin	36.63%	29.21%	44.67%	50.44%	-0.69%
Operating Margin	-46.72%	-46.31%	-1.71%	8.03%	-42.47%
Profit Margin	-76.76%	-35.38%	-14.01%	6.45%	-40.34%
Free Cash Flow Margin	-87.29%	-18.74%	-18.76%	53.33%	-44.61%
EBITDA	-6.18	-1.84	4.57	1.3	-1.98
EBITDA Margin	-24.04%	-9.71%	23.95%	29.79%	-21.04%
D&A For EBITDA	5.83	6.94	4.9	0.95	2.02
EBIT	-12.01	-8.78	-0.33	0.35	-4
EBIT Margin	-46.72%	-46.31%	-1.71%	8.03%	-42.47%

Updated Apr 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q